HDAd6/35++ – a New Helper-Dependent Adenovirus Vector Platform for In Vivo Transduction of Hematopoietic Stem Cells

Considering the impact of anti-Ad5/HDAd5/35++ neutralizing serum antibodies present in the human population, researchers generated HSC-retargeted HDAd6/35++ vectors derived from serotype 6.